Nombre de documents


CV de Sebastien Benzekry

Article dans une revue21 documents

  • Severine Mollard, Joseph Ciccolini, Diane-Charlotte Imbs, Raouf El Cheikh, Dominique Barbolosi, et al.. Model-driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis. Oncotarget, Impact journals, 2017, <10.18632/oncotarget.15484>. <hal-01474679>
  • Sébastien Benzekry. Les lois de la croissance tumorale. Bibliothèque Tangente, Editions Pôle Paris, 2016. <hal-01418295>
  • Pan Pantziarka, Lisa Hutchinson, Nicolas André, Sébastien Benzekry, Francesco Bertolini, et al.. Next generation metronomic chemotherapy - report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6 - 8 May 2016, Mumbai. Ecancermedicalscience, 2016, 10, <10.3332/ecancer.2016.689>. <hal-01392473>
  • S. Benzekry, A. Tracz, M. Mastri, R. Corbelli, D. Barbolosi, et al.. Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach. Cancer Research, American Association for Cancer Research, 2016, 76 (3), pp.535 - 547. <10.1158/0008-5472.CAN-15-1389>. <hal-01222046v2>
  • R. Serre, S. Benzekry, Laetitia Padovani, C. Meille, N. Andre, et al.. Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy. Cancer Research, American Association for Cancer Research, 2016, <10.1158/0008-5472.CAN-15-3567>. <hal-01336779>
  • Séverine Mollard, Raphaelle Fanciullino, Sarah Giacometti, Cindy Serdjebi, Sebastien Benzekry, et al.. In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling. Scientific Reports, Nature Publishing Group, 2016, 6, pp.10. <10.1038/srep36173>. <hal-01392861>
  • Sébastien Benzekry, Eddy Pasquier, Dominique Barbolosi, Bruno Lacarelle, Fabrice Barlési, et al.. Metronomic Reloaded: Theoretical Models Bringing Chemotherapy into the Era of Precision Medicine. Seminars in Cancer Biology, Elsevier, 2015, pp.23. <10.1016/j.semcancer.2015.09.002>. <hal-01195547>
  • Joseph Ciccolini, Sébastien Benzekry, Bruno Lacarelle, Dominique Barbolosi, Fabrice Barlési. Improving efficacy of the combination between antiangiogenic and chemotherapy: Time for mathematical modeling support. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2015, pp.1. <10.1073/pnas.1506689112>. <hal-01168635>
  • Sebastien Benzekry, Afshin Beheshti, Philip Hahnfeldt, Lynn Hlatky. Capturing the Driving Role of Tumor-Host Crosstalk in a Dynamical Model of Tumor Growth. bio-protocol, 2015, 5 (21), <>. <hal-01222068>
  • Afshin Beheshti, Sebastien Benzekry, J. Tyson Mcdonald, Lili Ma, Michael Peluso, et al.. Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression. Cancer Research, American Association for Cancer Research, 2015, 75 (6), pp.10. <10.1158/0008-5472.CAN-14-1053>. <hal-01132048>
  • Etienne Baratchart, Sébastien Benzekry, Andreas Bikfalvi, Thierry Colin, Lindsay S. Cooley, et al.. Computational Modelling of Metastasis Development in Renal Cell Carcinoma. PLoS Computational Biology, Public Library of Science, 2015, 11 (11), <10.1371/journal.pcbi.1004626>. <hal-01164834v2>
  • Sebastien Benzekry, Jack A Tuszynski, Edward Rietman, Giannoula Lakka Klement. Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks. Biology Direct, BioMed Central, 2015, pp.14. <10.1186/s13062-015-0058-5>. <hal-01158313>
  • Sebastien Benzekry, Alberto Gandolfi, Philip Hahnfeldt. Global Dormancy of Metastases due to Systemic Inhibition of Angiogenesis. PLoS ONE, Public Library of Science, 2014, 9 (1), pp.e84249. <10.1371/journal.pone.0084249>. <hal-00868592v3>
  • Sebastien Benzekry, Clare Lamont, Afshin Beheshti, Amanda Tracz, John M. Ebos, et al.. Classical Mathematical Models for Description and Forecast of Experimental Tumor Growth. PLoS Computational Biology, Public Library of Science, 2014, 10 (8), pp.e1003800. <10.1371/journal.pcbi.1003800>. <hal-00922553v6>
  • Sebastien Benzekry, Philip Hahnfeldt. Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.. Journal of Theoretical Biology, Elsevier, 2013, 335, pp.235-44. <10.1016/j.jtbi.2013.06.036>. <hal-00836032>
  • F. Lignet, S. Benzekry, S. Wilson, F. Billy, O. Saut, et al.. Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.. Journal of Theoretical Biology, Elsevier, 2013, 320, pp.86-99. <10.1016/j.jtbi.2012.12.013>. <hal-00785876>
  • Sébastien Benzekry, Guillemette Chapuisat, Joseph Ciccolini, Alice Erlinger, Florence Hubert. A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology. Comptes rendus de l'Académie des sciences. Série I, Mathématique, Elsevier, 2012, 350, pp.23-28. <10.1016/j.crma.2011.11.019>. <hal-00641476v2>
  • Sébastien Benzekry, Nicolas André, Assia Benabdallah, Joseph Ciccolini, Christian Faivre, et al.. Modeling the impact of anticancer agents on metastatic spreading. Mathematical Model Natural Phenomenon, 2012, 7 (1), pp 306--336. <10.1051/mmnp/20127114>. <hal-00657724>
  • Sebastien Benzekry. Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers. ESAIM: Mathematical Modelling and Numerical Analysis, EDP Sciences, 2012, 46 (2), pp.207-237. <hal-00518110>
  • Sebastien Benzekry. Passing to the limit 2D-1D in a model for metastatic growth. Journal of Biological Dynamics, Taylor & Francis Open, 2011, pp.10.1080/17513758.2011.568071. <10.1080/17513758.2011.568071>. <hal-00521968>
  • Sebastien Benzekry. Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis. Journal of Evolution Equations, Springer Verlag, 2011, 11 (1), pp.187-213. <hal-00516693>

Communication dans un congrès5 documents

  • Joseph Ciccolini, Sebastien Benzekry, Sarah Giacometti, Fabrice Barlesi, Dominique Barbolosi. Abstract 2099: Model-driven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice. 107th Annual Meeting of the American Association for Cancer Research, 2016, New Orleans, France. 76 (14 Supplement), pp.20, <10.1158/1538-7445.AM2016-2099>. <hal-01404637>
  • Sébastien Benzekry, John Ebos. On the growth and dissemination laws in a mathematical model of metastatic growth. Workshop on Multiscale and Hybrid Modelling in Cell and Cell Population Biology, Mar 2015, Paris, France. <10.1051/itmconf/20150500007>. <hal-01222088>
  • Séverine Mollard, Sébastien Benzekry, Giacometti Sarah, Christian Faivre, Florence Hubert, et al.. Model-based optimization of combined antiangiogenic + cytotoxics modalities: application to the bevacizumab-paclitaxel association in breast cancer models. AACR Annual Meeting 2014, Apr 2014, San Diego, United States. Cancer Res, 74; 3677, 74, 2014, Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. <10.1158/1538-7445.AM2014-3677>. <hal-01090883>
  • Sebastien Benzekry, Alberto Gandolfi, Philip Hahnfeldt. A mathematical model of systemic inhibition of angiogenesis in metastatic development. JP Dhersin. Congres SMAI 2013, May 2013, Seignosse, France. EDP Sciences, ESAIM: PROCEEDINGS AND SURVEYS, 45, pp.75-87, 2014, Congres SMAI 2013. <10.1051.201445008>. <hal-00867992>
  • Sebastien Benzekry, Nicolas André, Assia Benabdallah, J. Ciccolini, Christian Faivre, et al.. A mathematical mode for growing metastases on oncologist's service. M. Garbey and B. L. Bass and S. Bercelli and C. Collet and P. Cerveri. 3rd Annual International Conference in Computational Surgery, Jan 2011, houston, United States. 2013. <hal-00839331>

Rapport2 documents

  • Laura Lumale, Sébastien Benzekry. Around a mathematical model of the concomitant tumor resistance phenomenon . [Research Report] INRIA Bordeaux; Equipe MONC; INSA Toulouse. 2016. <hal-01420449>
  • Simon Evain, Sebastien Benzekry. Mathematical modeling of tumor and metastatic growth when treated with sunitinib. [Research Report] Inria Bordeaux Sud-Ouest. 2016. <hal-01377994>

Chapitre d'ouvrage1 document

  • Dominique Barbolosi, Assia Benabdallah, Sébastien Benzekry, Joseph Ciccolini, Christian Faivre, et al.. A Mathematical Model for Growing Metastases on Oncologists’s Service. Computational Surgery and Dual Training, Springer, pp.331 - 338, 2014, <10.1007/978-1-4614-8648-0_21>. <hal-01087708>

Pré-publication, Document de travail2 documents

  • Sebastien Benzekry, Dominique Barbolosi, Assia Benabdallah, Florence Hubert, Philip Hahnfeldt. Quantitative Analysis of the Tumor/Metastasis System and its Optimal Therapeutic Control. 2012. <hal-00836023>
  • Nina Aguillon, Sebastien Benzekry, Jérémie Bettinelli, Pierre Bochard, Nicolas Bonnotte, et al.. Semaine d'Etude Mathématiques et Entreprises 1 : Deux problèmes sur les parcs solaires.. 2011. <hal-00710024>